Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, the Netherlands.
Life Sci. 2024 Oct 15;355:122942. doi: 10.1016/j.lfs.2024.122942. Epub 2024 Aug 10.
Vitamin D's role in mineral homeostasis through its endocrine function, associated with the main circulating metabolite 25-hydroxyvitamin D, is well characterized. However, the increasing recognition of vitamin D's paracrine and autocrine functions-such as cell growth, immune function, and hormone regulation-necessitates examining vitamin D levels across different tissues post-supplementation. Hence, this review explores the biodistribution of vitamin D in blood and key tissues following oral supplementation in humans and animal models, highlighting the biologically active metabolite, 1,25-dihydroxyvitamin D, and the primary clearance metabolite, 24,25-dihydroxyvitamin D. While our findings indicate significant progress in understanding how circulating metabolite levels respond to supplementation, comprehensive insight into their tissue concentrations remains limited. The gap is particularly significant during pregnancy, a period of drastically increased vitamin D needs and metabolic alterations, where data remains sparse. Within the examined dosage ranges, both human and animal studies indicate that vitamin D and its metabolites are retained in tissues selectively. Notably, vitamin D concentrations in tissues show greater variability in response to administered doses. In contrast, its metabolites maintain a more consistent concentration range, albeit different among tissues, reflecting their tighter regulatory mechanisms following supplementation. These observations suggest that serum 25-hydroxyvitamin D levels may not adequately reflect vitamin D and its metabolite concentrations in different tissues. Therefore, future research should aim to generate robust human data on the tissue distribution of vitamin D and its principal metabolites post-supplementation. Relating this data to clinically appropriate exposure metrics will enhance our understanding of vitamin D's cellular effects and guide refinement of clinical trial methodologies.
维生素 D 通过其内分泌功能在矿物质稳态中的作用及其主要循环代谢产物 25-羟维生素 D 已得到充分描述。然而,人们越来越认识到维生素 D 的旁分泌和自分泌功能,如细胞生长、免疫功能和激素调节,这就需要在补充后检查不同组织中的维生素 D 水平。因此,本综述探讨了维生素 D 在人类和动物模型口服补充后在血液和关键组织中的分布情况,重点介绍了生物活性代谢物 1,25-二羟维生素 D 和主要清除代谢物 24,25-二羟维生素 D。虽然我们的研究结果表明,人们对循环代谢物水平对补充的反应有了显著的了解,但对其组织浓度的全面了解仍然有限。在怀孕期间,这种差距尤为明显,因为此时维生素 D 的需求和代谢变化急剧增加,但相关数据仍然很少。在所检查的剂量范围内,人类和动物研究均表明,维生素 D 及其代谢物在组织中具有选择性保留。值得注意的是,与给予的剂量相比,组织中维生素 D 的浓度变化更大。相比之下,其代谢物在补充后维持更一致的浓度范围,尽管在不同组织中有所不同,反映了它们更严格的调节机制。这些观察结果表明,血清 25-羟维生素 D 水平可能不能充分反映不同组织中维生素 D 及其代谢物的浓度。因此,未来的研究应旨在生成补充后维生素 D 及其主要代谢物在人体组织中分布的可靠数据。将这些数据与临床相关的暴露指标联系起来,将有助于我们更好地了解维生素 D 的细胞作用,并指导临床试验方法的改进。